My latest article in Washington Post’s Wonkblog responds to a New York Times series by Deborah Sontag, “Addiction treatment with a dark side,” which examines buprenorphine misuse as a substitution therapy. Buprenorphine is tool to treat opiate disorders, similar to methadone.
Though her piece was well-written, Sontag leaves readers with a misimpression of those with addiction and the treatments used to heal them.
To discuss these issues, I interviewed Brown University’s Peter Friedmann, a general internist, addiction medicine physician and one of the nation’s leading buprenorphine experts.
Read the full write-up here.